Dimensional Fund Advisors’s Array Biopharma Inc ARRY Stock Holding History

Dimensional Fund Advisors’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-407,674	Closed	-$18.9M	–	3489
2019 Q2	$18.9M	Buy	407,674 +43,281	+12%	+$1.22M	0.01%	2076
2019 Q1	$8.88M	Buy	+364,393	New	+$7.59M	﹤0.01%	2447
2016 Q3	–	Sell	-32,019	Closed	-$114K	–	3292
2016 Q2	$114K	Buy	+32,019	New	+$104K	﹤0.01%	3228
2014 Q3	–	Sell	-300	Closed	-$1K	–	3574
2014 Q2	$1K	Hold	300	–	–	﹤0.01%	3587
2014 Q1	$1K	Hold	300	–	–	﹤0.01%	3593
2013 Q4	$2K	Hold	300	–	–	﹤0.01%	3531
2013 Q3	$2K	Hold	300	–	–	﹤0.01%	3570
2013 Q2	$1K	Buy	+300	New	+$1.61K	﹤0.01%	3580

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return

Dimensional Fund Advisors's ARRY Position: Q3 2019 in Review

Dimensional Fund Advisors sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 407,674 shares — an estimated $18.9M sold.

Dimensional Fund Advisors first reported a position in ARRY in Q2 2013 and held it in 8 quarters. The position peaked at $18.9M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Dimensional Fund Advisors reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Dimensional Fund Advisors sold 407,674 Array Biopharma Inc shares in Q3 2019, an estimated $18.9M.
Dimensional Fund Advisors first reported a position in Array Biopharma Inc in Q2 2013 and held it in 8 quarters.
Dimensional Fund Advisors's Array Biopharma Inc position peaked at $18.9M in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Dimensional Fund Advisors's 13F filing for Q3 2019, filed 12 Nov 2019.